Abstract: Following the relaxation of pandemic control measures in China, the impact of coronavirus disease 2019 (COVID-19) on cognitive function in the Chinese population has not been investigated. Therefore, this study aimed to assess cognitive function and identify its risk factors in the subacute phase (<3 months) of COVID-19 patients during the epidemic wave of the Omicron variant. In this nationwide smartphone-based online assessment from January 15 to 29, 2023, the Integrated Cognitive Assessment (ICA) and the Number Ordering Test (NOT) were used to assess cognitive function. Among the 9663 participants, 8905 (92.2%) were COVID-19 survivors. These patients performed poorly on most neuropsychological results (P<0.05); however, after controlling for socio-demographics, only the ICA accuracies were lower (P<0.05, partial η²≤0.001). After the initial recovery, 5832 (65.5%) COVID-19 survivors reported inflexible thinking, 5419 (60.9%) noted slowed information processing speed, and 4344 (48.8%) reported insomnia. Female sex, older age, low education level, living in Northwest China, and insomnia were significantly associated with poor performance on the key neuropsychological results (range, absolute β values 0.023‒0.430, P<0.05). In the subacute phase of COVID-19, subjective cognitive complaints were highly prevalent, whereas objective cognitive differences were subtle. Despite the mild overall impact, vulnerable subgroups—such as females, older adults, individuals with low education level, and patients with insomnia—showed greater susceptibility to these cognitive changes.

中国奥密克戎变异株流行期间新冠患者亚急性期的认知功能研究

[1]Ariza M, Cano N, Segura B, et al., 2022. Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints. Front Aging Neurosci, 14:1029842.

[2]Bowie CR, Harvey PD, 2006. Administration and interpretation of the Trail Making Test. Nat Protoc, 1(5):2277-2281.

[3]Braga-Paz I, Ferreira de Araújo JL, Alves HJ, et al., 2022. Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: new clues to long-term cognitive disorders. Front Cell Infect Microbiol, 12:905757.

[4]Cavaco S, Sousa G, Gonçalves A, et al., 2023. Predictors of cognitive dysfunction one-year post COVID-19. Neuropsychology, 37(5):557-567.

[5]Cecchetti G, Agosta F, Canu E, et al., 2022. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol, 269(7):3400-3412.

[6]Chen AK, Wang XL, McCluskey LP, et al., 2022. Neuropsychiatric sequelae of long COVID-19: pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA. Brain Behav Immun Health, 24:100491.

[7]Chinese Center for Disease Control and Prevention, 2023. National COVID-19 infection situation (in Chinese). https://www.chinacdc.cn/jksj/xgbdyq/202411/t20241112_302571.html

[8]Crivelli L, Palmer K, Calandri I, et al., 2022. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement, 18(5):1047-1066.

[9]Delgado-Alonso C, Valles-Salgado M, Delgado-Álvarez A, et al., 2022. Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J Psychiatr Res, 150:40-46.

[10]Demmer RT, Cornelius T, Kraal Z, et al., 2025. COVID-19 and cognitive change in a community-based cohort. JAMA Netw Open, 8(6):e2518648.

[11]Diana L, Regazzoni R, Sozzi M, et al., 2023. Monitoring cognitive and psychological alterations in COVID-19 patients: a longitudinal neuropsychological study. J Neurol Sci, 444:120511.

[12]Douaud G, Lee S, Alfaro-Almagro F, et al., 2022. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature, 604(7907):697-707.

[13]Duindam HB, Kessels RPC, van den Borst B, et al., 2022. Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19. Brain Behav Immun Health, 25:100513.

[14]Frontera JA, Simon NM, 2022. Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19. JAMA Psychiatry, 79(8):811-817.

[15]Fu D, He GH, Li HL, et al., 2023. Effectiveness of COVID-19 vaccination against SARS-CoV-2 Omicron variant infection and symptoms—China, December 2022–February 2023. China CDC Wkly, 5(17):369-373.

[16]Gouraud C, Bottemanne H, Lahlou-Laforêt K, et al., 2021. Association between psychological distress, cognitive complaints, and neuropsychological status after a severe COVID-19 episode: a cross-sectional study. Front Psychiatry, 12:725861.

[17]Hampshire A, Chatfield DA, Manktelow A, et al., 2022. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine, 47:101417.

[18]Hampshire A, Azor A, Atchison C, et al., 2024. Cognition and memory after Covid-19 in a large community sample. N Engl J Med, 390(9):806-818.

[19]He DM, Yuan ML, Dang W, et al., 2023. Long term neuropsychiatric consequences in COVID-19 survivors: cognitive impairment and inflammatory underpinnings fifteen months after discharge. Asian J Psychiatr, 80:103409.

[20]Hosp JA, Dressing A, Blazhenets G, et al., 2021. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain, 144(4):1263-1276.

[21]Jaywant A, Gunning FM, Oberlin LE, et al., 2024. Cognitive symptoms of post–COVID-19 condition and daily functioning. JAMA Netw Open, 7(2):e2356098.

[22]Kalafatis C, Modarres MH, Apostolou P, et al., 2021. Validity and cultural generalisability of a 5-minute AI-based, computerised cognitive assessment in mild cognitive impairment and Alzheimer’s dementia. Front Psychiatry, 12:706695.

[23]Kaushik R, McAvay GJ, Murphy TE, et al., 2024. In-hospital delirium and disability and cognitive impairment after COVID-19 hospitalization. JAMA Netw Open, 7(7):e2419640.

[24]Khaligh-Razavi SM, Habibi S, Sadeghi M, et al., 2019. Integrated cognitive assessment: speed and accuracy of visual processing as a reliable proxy to cognitive performance. Sci Rep, 9:1102.

[25]Kim HY, 2013. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod, 38(1):52-54.

[26]Knapp SAB, Austin DS, Aita SL, et al., 2024. Neurocognitive and psychiatric outcomes associated with postacute COVID-19 infection without severe medical complication: a meta-analysis. J Neurol Neurosurg Psychiatry, 95(12):1207-1216.

[27]Kubota T, Kuroda N, Sone D, 2023. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin Neurosci, 77(2):84-93.

[28]Li X, Wu CQ, Lu JP, et al., 2020. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health, 5(12):e672-e681.

[29]Liu YH, Wang YR, Wang QH, et al., 2021. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener, 16:48.

[30]Liu YH, Chen Y, Wang QH, et al., 2022. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol, 79(5):509-517.

[31]Liu YH, Wu QX, Wang QH, et al., 2024. Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection. Nat Aging, 4(9):1186-1193.

[32]Miskowiak KW, Pedersen JK, Gunnarsson DV, et al., 2023. Cognitive impairments among patients in a long-COVID clinic: prevalence, pattern and relation to illness severity, work function and quality of life. J Affect Disord, 324:162-169.

[33]Molnar T, Lehoczki A, Fekete M, et al., 2024. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience, 46(5):5267-5286.

[34]Monje M, Iwasaki A, 2022. The neurobiology of long COVID. Neuron, 110(21):3484-3496.

[35]Nersesjan V, Fonsmark L, Christensen RHB, et al., 2022. Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non–COVID-19 illness. JAMA Psychiatry, 79(5):486-497.

[36]Ollila H, Pihlaja R, Koskinen S, et al., 2022. Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological study. Crit Care, 26:223.

[37]Peter RS, Nieters A, Brockmann SO, et al., 2023. Association of BMI with general health, working capacity recovered, and post-acute sequelae of COVID-19. Obesity (Silver Spring), 31(1):43-48.

[38]Pillay J, Rahman S, Guitard S, et al., 2022. Risk factors and preventive interventions for post Covid-19 condition: systematic review. Emerg Microbes Infect, 11(1):2762-2780.

[39]Pollini E, Lazzarini SG, Cordani C, et al., 2024. Effectiveness of rehabilitation interventions on adults with COVID-19 and post–COVID-19 condition. A systematic review with meta-analysis. Arch Phys Med Rehabil, 105(1):138-149.

[40]Schou TM, Joca S, Wegener G, et al., 2021. Psychiatric and neuropsychiatric sequelae of COVID-19–a systematic review. Brain Behav Immun, 97:328-348.

[41]Serrano del Pueblo VM, Serrano-Heras G, Romero Sánchez CM, et al., 2024. Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects. Brain, 147(10):3611-3623.

[42]Soriano JB, Murthy S, Marshall JC, et al., 2022. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis, 22(4):e102-e107.

[43]Taquet M, Sillett R, Zhu LN, et al., 2022. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry, 9(10):815-827.

[44]Taquet M, Skorniewska Z, de Deyn T, et al., 2024. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. Lancet Psychiatry, 11(9):696-708.

[45]Tavares-Júnior JWL, Oliveira DN, da Silva JBS, et al., 2022. Long-covid cognitive impairment: cognitive assessment and apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort. Front Psychiatry, 13:947583.

[46]Vakani K, Norbury R, Vanova M, et al., 2025. Cognitive function and brain structure in COVID-19 survivors: the role of persistent symptoms. Behav Brain Res, 476:115283.

[47]Valdes E, Fuchs B, Morrison C, et al., 2022. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19. J Neurol Sci, 438:120146.

[48]Vanderlind WM, Rabinovitz BB, Miao IY, et al., 2021. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr Opin Psychiatry, 34(4):420-433.

[49]Wang SW, Menor A, Chibnik LB, et al., 2025. COVID-19 pandemic–related exposures and cognitive function in middle-aged women. JAMA Netw Open, 8(4):e255532.

[50]Werheid K, Hoppe C, Thöne A, et al., 2002. The Adaptive Digit Ordering Test: clinical application, reliability, and validity of a verbal working memory test. Arch Clin Neuropsychol, 17(6):547-565.

[51]Wood GK, Sargent BF, Ahmad ZUA, et al., 2025. Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction. Nat Med, 31:245-257.

[52]Yaffe K, Falvey CM, Hoang T, 2014. Connections between sleep and cognition in older adults. Lancet Neurol, 13(10):1017-1028.

[53]Zamarian L, Rass V, Goettfried E, et al., 2024. Objective and subjective cognitive outcomes one year after COVID-19. Ann Clin Transl Neurol, 11(9):2360-2371.

[54]Zeraatkar D, Ling M, Kirsh S, et al., 2024. Interventions for the management of long covid (post-covid condition): living systematic review. BMJ, 387:e081318.

[55]Zhou HT, Lu SJ, Chen JK, et al., 2020. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res, 129:98-102.

Similar articles